Literature DB >> 27775735

Transparency is good, independence from pharmaceutical industry is better!

Agnes Vitry1.   

Abstract

Keywords:  Medicines Australia; advertising; drug industry

Year:  2016        PMID： 27775735      PMCID： PMC4993711          DOI： 10.18773/austprescr.2016.051

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  3 in total

1.  All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.

Authors:  Dana Katz; Arthur L Caplan; Jon F Merz
Journal:  Am J Bioeth       Date:  2003       Impact factor: 11.229

2.  Pharmaceutical industry exposure in our hospitals: the final frontier.

Authors:  Jessica Dean; Erwin Loh; Justin J Coleman
Journal:  Med J Aust       Date:  2016-01-18       Impact factor: 7.738

Review 3.  Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.

Authors:  Geoffrey K Spurling; Peter R Mansfield; Brett D Montgomery; Joel Lexchin; Jenny Doust; Noordin Othman; Agnes I Vitry
Journal:  PLoS Med       Date:  2010-10-19       Impact factor: 11.069
  3 in total
  2 in total

1.  Changes in the type and amount of spending disclosed by Australian pharmaceutical companies: an observational study.

Authors:  Lisa Parker; Emily A Karanges; Lisa Bero
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

2.  Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries.

Authors:  Alice Fabbri; Ancel la Santos; Signe Mezinska; Shai Mulinari; Barbara Mintzes
Journal:  Int J Health Policy Manag       Date:  2018-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.